mcn 5691 has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almond, HR; Brannan, MD; Carmosin, RJ; Carson, JR; Flaim, SF; Gill, A; Gleason, MM; Keely, SL; Ludovici, DW; Pitis, PM | 1 |
| Brannan, MD; Carson, JR; Flaim, SF; Gill, A; Stranieri, MT | 1 |
2 other study(ies) available for mcn 5691 and Blood Pressure, High
| Article | Year |
|---|---|
2-Ethynylbenzenealkanamines. A new class of calcium entry blockers.
Topics: Alkynes; Amines; Animals; Calcium Channel Blockers; Coronary Circulation; Guinea Pigs; Hypertension; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Vasodilation | 1988 |
Effects of the novel calcium channel blocker, McN-5691, on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rat.
Topics: Animals; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Hemodynamics; Hypertension; Infusions, Intravenous; Male; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance | 1988 |